Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone augmentation of exposure therapy for social anxiety disorder in women
NL-OMON44812Active, not recruiting
- Sponsor
- Radboud University
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of testosterone in Social Anxiety Disorder (SAD), sponsored by Radboud University. Primary endpoint: Subjective anxiety during exposure. Started Jun 2017; status: active, not recruiting.
02
Drugs
testosterone
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NL-OMON44812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44812.